Under construction – not a live service
Sign in
Not yet taking people in ItalyNo phase

Checking metabolic health in young children with congenital hypothyroidism

Observes metabolic risk in children aged 5 to 12 with congenital hypothyroidism.

Plain-language title generated from the registry record
Registry title: Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism

Key facts

Where
Milan, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 5 and 12 years old?

Source: NCT07126353, who can take part

Where in Italy

  • Buzzi Children's HospitalMilan, ItalyNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Buzzi Children's Hospital
Trial code
NCT07126353
Record updated
17 August 2025
Original description
We propose a multicenter prospective study to define the prevalence and severity score of metabolic syndrome in a prepubertal pediatric cohort with congenital hypothyroidism, compared to a healthy and normal-weight pediatric population. These data will help to define whether hypothyroidism can be considered a risk factor for the metabolic health of the pediatric population. The possible identification of an at-risk metabolic profile will provide useful information to optimize the diagnostic and monitoring pathway for affected children.Read full original descriptionShow less

Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism (IpoMet)

We propose a multicenter prospective study to define the prevalence and severity score of metabolic syndrome in a prepubertal pediatric cohort with congenital hypothyroidism, compared to a healthy and normal-weight pediatric population. These data will help to define whether hypothyroidism can be considered a risk factor for the metabolic health of the pediatric population. The possible identification of an at-risk metabolic profile will provide useful information to optimize the diagnostic and monitoring pathway for affected children.

Inclusion: Pubertal stage Tanner 1; Permanent congenital hypothyroidism; All ethnic groups; Informed consent signature.

Exclusion: Age< 5 years; Pubertal stage Tanner 2-5; Transient congenital hypothyroidism or other type of hypothyroidism.

ClinicalTrials.gov NCT07126353